良医汇-肿瘤医生

Downloads
Revenue

Description

N/A

In-Apps

6学习币
9.00 r
30学习币
39.00 r
98学习币
129.00 r
158学习币
199.00 r
198学习币
249.00 r
298学习币
399.00 r
588学习币
799.00 r
4998学习币
6,999.00 r

Screenshots

Loading...
Please wait..

良医汇-肿瘤医生 FAQ

  • Is 良医汇-肿瘤医生 free?

    Yes, 良医汇-肿瘤医生 is free to download, however it contains in-app purchases or subscription offerings.

  • Is 良医汇-肿瘤医生 legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does 良医汇-肿瘤医生 cost?

    良医汇-肿瘤医生 has several in-app purchases/subscriptions, the average in-app price is 1,102.75 r.

  • What is 良医汇-肿瘤医生 revenue?

    To get estimated revenue of 良医汇-肿瘤医生 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Denmark yet.
Ratings History

良医汇-肿瘤医生 Reviews

No Reviews in Denmark
App doesn't have any reviews in Denmark yet.

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
Chart
Category
Rank
Top Free
345
Top Free
352

良医汇-肿瘤医生 Competitors

Name
医脉通-医生的临床决策好帮手
医学资讯传递,病例实战宝典
梅斯医学 - 医路相伴,成就大医
大专家医生版
CSCO
TalkMED
好大夫医生版
线上线下结合的执业新方式
肿瘤指南者医生端
药研社
解螺旋
医生数智化学术成长平台
咚咚肿瘤科
临床决策、干货经验、知识和结论

良医汇-肿瘤医生 Installs

Last 30 days

良医汇-肿瘤医生 Revenue

Last 30 days

良医汇-肿瘤医生 Revenue and Downloads

Gain valuable insights into 良医汇-肿瘤医生 performance with our analytics.
Sign up now to access downloads, revenue, and more.

App Info

Category
Medical
Languages
English, Chinese
Recent release
9.7.24 (2 weeks ago )
Released on
Sep 4, 2015 (9 years ago )
Last Updated
3 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.